ABS 205
Alternative Names: ABS 200Latest Information Update: 11 Dec 2002
At a glance
- Originator University College Dublin
- Developer American Biogenetic Sciences [CEASED]
- Class
- Mechanism of Action Nerve growth factor stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Alzheimer's disease; Parkinson's disease; Schizophrenia
Most Recent Events
- 25 Sep 2002 Discontinued - Preclinical for Alzheimer's disease in USA (unspecified route)
- 25 Sep 2002 Discontinued - Preclinical for Parkinson's disease in USA (unspecified route)
- 25 Sep 2002 Discontinued - Preclinical for Schizophrenia in USA (unspecified route)